Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Non-cash Items: 2019-2021

Historic Non-cash Items for Nurix Therapeutics (NRIX) over the last 3 years, with Nov 2021 value amounting to $57.9 million.

  • Nurix Therapeutics' Non-cash Items rose 56.47% to $85.9 million in Q3 2022 from the same period last year, while for Aug 2022 it was $85.9 million, marking a year-over-year increase of 56.47%. This contributed to the annual value of $57.9 million for FY2021, which is 59.01% down from last year.
  • Nurix Therapeutics' Non-cash Items amounted to $57.9 million in FY2021, which was down 59.01% from $141.2 million recorded in FY2020.
  • In the past 5 years, Nurix Therapeutics' Non-cash Items ranged from a high of $141.2 million in FY2020 and a low of $762,000 during FY2019.
  • In the last 3 years, Nurix Therapeutics' Non-cash Items had a median value of $57.9 million in 2021 and averaged $66.6 million.
  • In the last 5 years, Nurix Therapeutics' Non-cash Items soared by 18,436.61% in 2020 and then tumbled by 59.01% in 2021.
  • Over the past 3 years, Nurix Therapeutics' Non-cash Items (Yearly) stood at $762,000 in 2019, then soared by 18,436.61% to $141.2 million in 2020, then plummeted by 59.01% to $57.9 million in 2021.